The drug 5-Fluorouracil (5-FU) has been the first choice to treat colorectal cancer for years. In addition to the common side effects of chemotherapy, the usage of 5-FU may also lead to increased risk of infection and anaemia. In light of 5-FU's high cytotoxicity and low bioavailability, our technology may provide another option of anti-cancer drug with fewer side effects.
Aspiring to be a leading, research-led, liberal arts University in Asia, Hong Kong Baptist University is committed to conducting world-leading investigations that extends the frontiers of knowledge, tackles global challenges and benefits the community at home and abroad.
Pursuing research excellence is one of the priorities of the University’s Institutional Strategic Plan 2018-2028. The University keeps enhancing its capacity and strength to produce world-class research with an aim to bring significant impact to the society.